Photo of Peter Söderkvist

Peter Söderkvist

-

Publications

2026

Malgorzata Trybula, Malgorzata Lysiak, Emilia Wiechec, Annika Malmström, Peter Söderkvist (2026) GLUD1 Inhibition Disrupts Glutamate Homeostasis and Induces Metabolic and Redox Stress in Gliomas Cells, Vol. 15, Article 1401 (Article in journal) https://dx.doi.org/10.3390/cells15151401
Mouna Tababi, Malgorzata Lysiak, Oliver Gimm, Peter Söderkvist (2026) Integrative Epigenomic and Transcriptomic Profiling Define Malignancy- and Cluster-Specific Signatures in Pheochromocytomas and Paragangliomas Cells, Vol. 15, Article 198 (Article in journal) https://dx.doi.org/10.3390/cells15020198

2025

Mouna Tababi, Sallam Abdallah, Ahmed Elserafy, Peter Söderkvist, Oliver Gimm (2025) Role of GDH and PARP inhibitors as novel treatments for SDHB-deficient PPGLs Endocrine-Related Cancer, Vol. 32, Article e250173 (Article in journal) https://dx.doi.org/10.1530/ERC-25-0173

2023

Christian Lundtoft, Daniel Eriksson, Matteo Bianchi, Maribel Aranda-Guillen, Nils Landegren, Solbritt Rantapaa-Dahlqvist, Peter Söderkvist, Jeniffer R. S. Meadows, DISSECT Consortium, Immunoarray Consortium, Swedish Addison Registry Study Grp, Gerli Rosengren Pielberg, Sophie Bensing, Gerli Rosengren Pielberg, Kerstin Lindblad-Toh, Lars Ronnblom, Olle Kampe (2023) Relation between HLA and copy number variation of steroid 21-hydroxylase in a Swedish cohort of patients with autoimmune Addisons disease European Journal of Endocrinology, Vol. 189, p. 235-241 (Article in journal) https://dx.doi.org/10.1093/ejendo/lvad102
Mouna Tababi, Peter Söderkvist, Oliver Gimm (2023) Nuclear and mitochondrial DNA alterations in pheochromocytomas and paragangliomas, and their potential treatment Endocrine-Related Cancer, Vol. 30, Article e220217 (Article, review/survey) https://dx.doi.org/10.1530/ERC-22-0217

Network

Organisation